Journal of hepatologyJClub
Surveillance of patients at risk of liver cancer: Expert opinions.
Journal of hepatology · · Review · Open access
Yip, Innes + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Liver cancer surveillance lacks randomized trial evidence, with most positive results being false positives in low-prevalence populations, limiting support beyond hepatology.
- Why it matters: This gap hampers the development of effective screening programs and prevents broader endorsement by national screening authorities, risking suboptimal patient outcomes.
- What they did: The authors reviewed observational research, acknowledged the absence of randomized trials, and discussed the challenges of current screening modalities, including false positives and weak evidence.
- The result: Advancing risk-based surveillance and gathering stronger evidence could improve detection accuracy and survival benefits, guiding future screening practices and policy support.
The findingWhy it mattersWhat they didThe result
- Open access
- 1 cites